With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for the upcoming oral options will be the sector’s next great challenge.
With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for the upcoming oral options will be the sector’s next great challenge.